Literature DB >> 7109845

Loperamide in rat intestines: a unique disposition.

H Miyazaki, K Nambu, M Hashimoto.   

Abstract

When everted sacs of rat duodenum, jejunum and ileum were incubated with [14C]loperamide in vitro, unchanged drug and its metabolites were found not only in tissues but also in media of the mucosal side with virtually no radioactivity in media of the serosal side. The amounts of metabolites found in media of the mucosal side were comparable to or larger than those in tissues. Di-desmethyl loperamide was more predominant in the media as compared with mono-demethylated one than in the tissues. Therefore, a portion of loperamide absorbed in intestines can be metabolized there and directly secreted back into lumen. Oral loperamide thus undergoes a unique disposition, likely constituting one of mechanisms for its distinct dissociation of central and antidiarrheal activities.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7109845     DOI: 10.1016/0024-3205(82)90294-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Effect of increasing oral doses of loperamide on gallbladder motility in man.

Authors:  W P Hopman; G Rosenbusch; J B Jansen; C B Lamers
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

2.  Difenoxin and loperamide: studies on possible mechanisms of intestinal antisecretory action.

Authors:  A De Luca; I M Coupar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

3.  Unexpected prosecretory action component of loperamide at mu-opioid receptors in the guinea-pig colonic mucosa in vitro.

Authors:  W Kromer
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

4.  State-dependent inhibition of BK channels by the opioid agonist loperamide.

Authors:  Alexandre G Vouga; Michael E Rockman; Jiusheng Yan; Marlene A Jacobson; Brad S Rothberg
Journal:  J Gen Physiol       Date:  2021-08-06       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.